Canada· CA-DIN-02490773

ERTAPENEM FOR INJECTION

A ertapenem product containing ertapenem (ertapenem sodium), registered in Canada by JUNO PHARMACEUTICALS CORP.. The same ATC class is registered in 16 of our 19 countries.

ATC J01DH03

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ertapenem (ertapenem sodium)Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ertapenem is registered in 16 of 19 countries.

Countries holding a registration under ATC J01DH03 (ertapenem), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
9 of them publish a price we can compare per daily dose

Search ertapenem products by name

Ertapenem · ATC J01DH03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ertapenem costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ertapenem · price per daily dose (1 g)

USD · FX 28 Sept 2026

CH Switzerland$74.64

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: ERTAPENEM (ERTAPENEM SODIUM)
Manufacturer: JUNO PHARMACEUTICALS CORP.
Country: Canada (CA)
ATC code: J01DH03
ATC class: Ertapenem
Defined daily dose: 1 g, P
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for ertapenem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ertapenem against other medicines How interaction checks work

Ertapenem · interactions on record

56 records

4 severe
13 moderate
38 info

Most severe, free to view

BupropionN06AX12severe
BupropionN07BA02severe
IohexolV08AB02severe
IopamidolV08AB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ertapenem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ertapenem products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Bulgaria · Ертапенем Аптафарма
Cyprus · Ertapenem Aptapharma
Czechia · Ertapenem Aptapharma, Ertapenem Ash
Germany · Ertapenem Steriscience
Denmark · Ertapenem "aptapharma", Ertapenem Fresenius Kabi
Estonia · Ertapenem Fresenius Kabi, Ertapenem Qilu
Spain · Ertapenem, Ertapenem Aurovitas
Finland · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
France · Ertapenem Acs Dobfar, Ertapenem Arrow
United Kingdom (Northern Ireland) · Ertapenem Acs Dobfar, Ertapenem Aspire Pharma
Greece · Ertapenem Anfarm
Croatia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Hungary · Ertapenem Anfarm, Ertapenem Aptapharma
Iceland · Invanz
Italy · Ertapenem Acs Dobfar, Ertapenem Aurobindo
Liechtenstein · Invanz
Lithuania · Ertapenem Qilu
Latvia · Ertapenem Qilu
Malta · Ertapenem Aptapharma
Netherlands · Ertapenem Added Pharma, Ertapenem Aptapharma
Norway · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Poland · Ertapenem Aptapharma, Ertapenem Eugia
Portugal · Ertapenem, Ertapenem Aurovitas
Romania · Ertapenem Acs Dobfar, Ertapenem Aptapharma
Sweden · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Slovenia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Slovakia · Ertapenem Aptapharma, Ertapenem Ash

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/91026e74-ae74-4b37-bae0-ef65825fa784
GET /v1/drugs/91026e74-ae74-4b37-bae0-ef65825fa784?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02490773",
  "form": "POWDER FOR SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS",
    "INTRAMUSCULAR"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J01DH03",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "98083",
  "strengths": [
    "1 G"
  ],
  "ahfs_class": null,
  "substances": [
    "ERTAPENEM (ERTAPENEM SODIUM)"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about ertapenem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console